Algert Global LLC Acrivon Therapeutics, Inc. Transaction History
Algert Global LLC
- $5.98 Billion
- Q3 2025
A detailed history of Algert Global LLC transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 44,648 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.